{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:38:57Z","timestamp":1760524737616,"version":"build-2065373602"},"reference-count":32,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dr. Vlad Bogin"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>The Hippocratic principle primum non nocere, or \u201cfirst, do no harm\u201d, serves as a vital lens through which to re-evaluate modern oncology practices. While recent advances such as immunotherapy, targeted agents, and precision medicine have transformed cancer care, these treatments are not without risk. Even with improved tolerability, they may still lead to substantial toxicities, particularly in frail patients with advanced cancer. The pursuit of survival often overshadows the patient\u2019s quality of life, with aggressive interventions frequently continuing beyond the point of meaningful benefit. This perspective article argues for a more individualized and ethically grounded approach to cancer treatment, emphasizing the careful assessment of each patient\u2019s clinical status, values, and goals. By integrating geriatric and palliative assessments, improving shared decision making, and moving away from a default treatment-at-all-costs mindset, clinicians can better align care with what truly matters to patients. Honoring primum non nocere in oncology means not only extending life when appropriate but ensuring that life remains worth living.<\/jats:p>","DOI":"10.3390\/medicina61050918","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T08:41:12Z","timestamp":1747730472000},"page":"918","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["We Need to Talk About Quality of Life with Cancer Patients: Primum Non Nocere in Oncology"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2428-7563","authenticated-orcid":false,"given":"Vlad","family":"Bogin","sequence":"first","affiliation":[{"name":"Suite 300, Preston Commons Center, 8117 Preston Road, Dallas, TX 75225, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e2037120","DOI":"10.1001\/jamanetworkopen.2020.37120","article-title":"Association of Performance Status with Survival in Patients with Advanced Non\u2013Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy","volume":"4","author":"Sehgal","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Muhandiramge, J., Orchard, S.G., Warner, E.T., van Londen, G.J., and Zalcberg, J.R. (2022). Functional Decline in the Cancer Patient: A Review. Cancers, 14.","DOI":"10.3390\/cancers14061368"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","article-title":"Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology","volume":"36","author":"Mohile","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e223039","DOI":"10.1001\/jamanetworkopen.2022.3039","article-title":"Association of Oncologist-Patient Communication with Functional Status and Physical Performance in Older Adults: A Secondary Analysis of a Cluster Randomized Clinical Trial","volume":"5","author":"Lei","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lungcan.2019.03.009","article-title":"Understanding patients\u2019 values and preferences regarding early stage lung cancer treatment decision making","volume":"131","author":"Sullivan","year":"2019","journal-title":"Lung Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_7","first-page":"625","article-title":"Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1111\/jns.12335","article-title":"Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment","volume":"24","author":"Staff","year":"2019","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Starobova, H., and Vetter, I. (2017). Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. Front. Mol. Neurosci., 10.","DOI":"10.3389\/fnmol.2017.00174"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e002890","DOI":"10.1136\/jitc-2021-002890","article-title":"Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors","volume":"9","author":"Guidon","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","article-title":"Cisplatin nephrotoxicity: New insights and therapeutic implications","volume":"19","author":"Tang","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","article-title":"Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer","volume":"34","author":"Frisina","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropaenia: ESMO Clinical Practice Guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-Related Adverse Events Associated with Immune Checkpoint Blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"176614","DOI":"10.1016\/j.ejphar.2024.176614","article-title":"Mechanisms and emerging strategies for irinotecan-induced diarrhea","volume":"974","author":"Xu","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e007409","DOI":"10.1136\/jitc-2023-007409","article-title":"Corticosteroid-resistant immune-related adverse events: A systematic review","volume":"12","author":"Daetwyler","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"ref_18","first-page":"CD010257","article-title":"Antibiotics for exacerbations of chronic obstructive pulmonary disease","volume":"10","author":"Vollenweider","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1758835920905408","DOI":"10.1177\/1758835920905408","article-title":"Systematic review and meta-analysis of gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer","volume":"12","author":"Camandaroba","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/jamainternmed.2019.0462","article-title":"Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval","volume":"179","author":"Gyawali","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jamaoncol.2024.1129","article-title":"Systemic anticancer therapy and overall survival in patients with very advanced solid tumors","volume":"10","author":"Canavan","year":"2024","journal-title":"JAMA Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jamaoncol.2015.2378","article-title":"Chemotherapy use, performance status, and quality of life at the end of life","volume":"1","author":"Prigerson","year":"2015","journal-title":"JAMA Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2440977","DOI":"10.1001\/jamanetworkopen.2024.40977","article-title":"Timing of Palliative Care, End-of-Life Quality Indicators, and Health Resource Utilization","volume":"7","author":"Mah","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e2426304","DOI":"10.1001\/jamanetworkopen.2024.26304","article-title":"Early integrated palliative care in patients with advanced cancer: A randomized clinical trial","volume":"7","author":"Kang","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100225","DOI":"10.1016\/j.esmoop.2021.100225","article-title":"Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines","volume":"6","author":"Crawford","year":"2021","journal-title":"ESMO Open"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2012.43.6055","article-title":"Associations between end-of-life discussion characteristics and care received near death: A prospective cohort study","volume":"30","author":"Mack","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00520-020-05750-0","article-title":"The silent transition from curative to palliative treatment: A qualitative study about cancer patients\u2019 perceptions of end-of-life discussions with oncologists","volume":"29","author":"Kitta","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/SPC.0b013e3283528d0c","article-title":"Evolving definitions of hope in oncology","volume":"6","author":"Olver","year":"2012","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1634\/theoncologist.5-4-302","article-title":"SPIKES-A six-step protocol for delivering bad news: Application to the patient with cancer","volume":"5","author":"Baile","year":"2000","journal-title":"Oncologist"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e1364","DOI":"10.1097\/PTS.0000000000000491","article-title":"Disclosure Coaching: An Ask-Tell-Ask Model to Support Clinicians in Disclosure Conversations","volume":"17","author":"Shapiro","year":"2021","journal-title":"J. Patient Saf."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/5\/918\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:34:59Z","timestamp":1760031299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/5\/918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["medicina61050918"],"URL":"https:\/\/doi.org\/10.3390\/medicina61050918","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,5,19]]}}}